Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Pediatr Hematol Oncol ; 44(8): 474-478, 2022 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-35731920

RESUMO

Laminin alpha-2-related muscular dystrophy ( LAMA2 -MD), caused by mutations in the LAMA2 gene, is inherited in an autosomal recessive manner. There is no known association of LAMA2 -MD with cancer predisposition. We present a 4-year-old female with LAMA2 -MD and Children's Oncology Group stage III diffuse anaplastic Wilms tumor (DAWT). Given our patient's comorbidities, it was essential to tailor her adjuvant chemotherapy by omitting vincristine and doxorubicin to avoid the potential worsening of her neuromuscular dysfunction and cardiomyopathy. This report illustrates the sporadic occurrence of 2 rare events in our patient and highlights the successful risk-adapted management of DAWT based on the pathophysiology of LAMA2 -MD.


Assuntos
Neoplasias Renais , Distrofias Musculares , Tumor de Wilms , Criança , Feminino , Humanos , Pré-Escolar , Distrofias Musculares/genética , Distrofias Musculares/patologia , Tumor de Wilms/genética , Mutação , Vincristina , Neoplasias Renais/tratamento farmacológico , Neoplasias Renais/genética , Neoplasias Renais/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA